Skip to main content
NCBI home page
The Kaohsiung Journal of Medical Sciences logoLink to The Kaohsiung Journal of Medical Sciences
. 2009 Jul 22;25(7):366–373. doi: 10.1016/S1607-551X(09)70529-7

Determinants of Peripheral Arterial Stiffness in Patients With Chronic Kidney Disease in Southern Taiwan

Jui‐Hsin Chen 1, Szu‐Chia Chen 2, Wan‐Chun Liu 2, Ho‐Ming Su 2, Chiu‐Yueh Chen 1, Hsiu‐Chin Mai 1, Ming‐Chin Chou 1, Jer‐Ming Chang 2,3,✉
PMCID: PMC11917606  PMID: 19605328

Abstract

High prevalences of peripheral artery occlusive disease (PAOD) and increased arterial stiffness have been reported in patients with chronic kidney disease (CKD). However, these have not been assessed in Taiwan where the prevalence of CKD is high. The aim of this study was to investigate the determinants of PAOD and arterial stiffness in patients with CKD in southern Taiwan. We enrolled 169 patients with stage 3–5 CKD in one regional hospital. Ankle‐brachial index (ABI) and brachial‐ankle pulse wave velocity were measured using an ABI‐form device (Colin VP1000). In multivariate analysis, ABI < 0.9 was positively correlated with the presence of diabetes mellitus (p = 0.014) and negatively correlated with the estimated glomerular filtration rate (eGFR) (p = 0.049), and increased brachial‐ankle pulse wave velocity was correlated with increased age, diabetes mellitus, increased systolic blood pressure, decreased pulse pressure and decreased eGFR. This study identified determinants of PAOD and arterial stiffness in patients with CKD in one hospital in southern Taiwan. In addition to the traditional atherosclerotic risk factors, decreased eGFR was also correlated with PAOD and increased arterial stiffness in these patients.

Keywords: ankle‐brachial index, arterial stiffness, brachial‐ankle pulse wave velocity, chronic kidney disease, peripheral artery occlusive disease

Full Text

The Full Text of this article is available as a PDF (292.1 KB).

References

  • 1. Guerrero A, Montes R, Munoz‐Terol J, et al. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant. 2006; 21: 3525–3531. [DOI] [PubMed] [Google Scholar]
  • 2. Kawamoto R, Kohara K, Tabara Y, et al. An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med. 2008; 47: 593–598. [DOI] [PubMed] [Google Scholar]
  • 3. Leskinen Y, Salenius JP, Lehtimaki T, et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis. 2002; 40: 472–479. [DOI] [PubMed] [Google Scholar]
  • 4. Nakagawa N, Takahashi F, Chinda J, et al. A newly estimated glomerular filtration rate is independently associated with arterial stiffness in Japanese patients. Hypertens Res. 2008; 31: 193–201. [DOI] [PubMed] [Google Scholar]
  • 5. O'Hare AM, Glidden DV, Fox CS, et al. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999–2000. Circulation. 2004; 109: 320–323. [DOI] [PubMed] [Google Scholar]
  • 6. Ohya Y, Iseki K, Iseki C, et al. Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am J Kidney Dis. 2006; 47: 790–797. [DOI] [PubMed] [Google Scholar]
  • 7. Fishbane S, Youn S, Kowalski EJ, et al. Ankle‐arm blood pressure index as a marker for atherosclerotic vascular diseases in hemodialysis patients. Am J Kidney Dis. 1995; 25: 34–39. [DOI] [PubMed] [Google Scholar]
  • 8. Fowkes FG, Housley E, Cawood EH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991; 20: 384–392. [DOI] [PubMed] [Google Scholar]
  • 9. Newman AB, Tyrrell KS, Kuller LH. Mortality over four years in SHEP participants with a low ankle‐arm index. J Am Geriatr Soc. 1997; 45: 1472–1478. [DOI] [PubMed] [Google Scholar]
  • 10. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002; 39: 10–15. [DOI] [PubMed] [Google Scholar]
  • 11. Lehmann ED. Clinical value of aortic pulse‐wave velocity measurement. Lancet. 1999; 354: 528–529. [DOI] [PubMed] [Google Scholar]
  • 12. Chen SC, Su HM, Mai HC, et al. Associated risk factors for abnormal ankle‐brachial index in hemodialysis patients in a hospital. Kaohsiung J Med Sci. 2008; 24: 473–480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. National Kidney Foundation . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39 (2 Suppl 1): S1–266. [PubMed] [Google Scholar]
  • 14. Tomiyama H, Yamashina A, Arai T, et al. Influences of age and gender on results of noninvasive brachialankle pulse wave velocity measurement—a survey of 12517 subjects. Atherosclerosis. 2003; 166: 303–309, Erratum in: Atherosclerosis. 30: 2003; 3. [DOI] [PubMed] [Google Scholar]
  • 15. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial‐ankle pulse wave velocity measurement. Hypertens Res. 2002; 25: 359–364. [DOI] [PubMed] [Google Scholar]
  • 16. Yokoyama H, Shoji T, Kimoto E, et al. Pulse wave velocity in lower‐limb arteries among diabetic patients with peripheral arterial disease. J Atheroscler Thromb. 2003; 10: 253–258. [DOI] [PubMed] [Google Scholar]
  • 17. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter‐Society Consensus (TASC). J Vasc Surg. 2000; 31 (1 Pt 2): S1–296. [PubMed] [Google Scholar]
  • 18. Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care. 2004; 27: 1182–1186. [DOI] [PubMed] [Google Scholar]
  • 19. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461–470. [DOI] [PubMed] [Google Scholar]
  • 20. de Vinuesa SG, Ortega M, Martinez P, et al. Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors. Kidney Int Suppl. 2005; 93: S44–S47. [DOI] [PubMed] [Google Scholar]
  • 21. Levin A, Djurdjev O, Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis. 2001; 38: 1398–1407. [DOI] [PubMed] [Google Scholar]
  • 22. Shinohara K, Shoji T, Tsujimoto Y, et al. Arterial stiffness in predialysis patients with uremia. Kidney Int. 2004; 65: 936–943. [DOI] [PubMed] [Google Scholar]
  • 23. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000; 58: 353–362. [DOI] [PubMed] [Google Scholar]
  • 24. Matsumae T, Abe Y, Murakami G, et al. Determinants of arterial wall stiffness and peripheral artery occlusive disease in nondiabetic hemodialysis patients. Hypertens Res. 2007; 30: 377–385. [DOI] [PubMed] [Google Scholar]
  • 25. O'Hare AM, Hsu CY, Bacchetti P, et al. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol. 2002; 13: 497–503. [DOI] [PubMed] [Google Scholar]
  • 26. Ono K, Tsuchida A, Kawai H, et al. Ankle‐brachial blood pressure index predicts all‐cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol. 2003; 14: 1591–1598. [DOI] [PubMed] [Google Scholar]
  • 27. Stancanelli B, Malatino LS, Malaponte G, et al. Pulse pressure is an independent predictor of aortic stiffness in patients with mild to moderate chronic kidney disease. Kidney Blood Press Res. 2007; 30: 283–288. [DOI] [PubMed] [Google Scholar]
  • 28. Bakris GL. Clinical importance of microalbuminuria in diabetes and hypertension. Curr Hypertens Rep. 2004; 6: 352–356. [DOI] [PubMed] [Google Scholar]
  • 29. Segura J, Campo C, Ruilope LM. Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int Suppl. 2004; 92: S45–S49. [DOI] [PubMed] [Google Scholar]
  • 30. Kohara K, Tabara Y, Tachibana R, et al. Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J‐SHIPP) study. Hypertens Res. 2004; 27: 471–477. [DOI] [PubMed] [Google Scholar]
  • 31. Yokoyama H, Hirasawa K, Aoki T, et al. Brachial‐ankle pulse wave velocity measured automatically by oscillometric method is elevated in diabetic patients with incipient nephropathy. Diabet Med. 2003; 20: 942–945. [DOI] [PubMed] [Google Scholar]
  • 32. Smith A, Karalliedde J, De Angelis L, et al. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol. 2005; 16: 1069–1075. [DOI] [PubMed] [Google Scholar]
  • 33. Richbourg MJ. Whatever happened to foot care? Preventing amputations in patients with end stage renal disease. EDTNA ERCA J. 1998; 24: 4–10. [PubMed] [Google Scholar]
  • 34. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18–20, 1992 New Orleans, Louisiana. Circulation. 1993; 88: 819–828. [DOI] [PubMed] [Google Scholar]
  • 35. Chen SC, Chang JM, Hwang SJ, et al. Comparison of ankle‐brachial index and brachial‐ankle pulse wave velocity between patients with chronic kidney disease and hemodialysis. Am J Nephrol. 2008; 29: 374–380. [DOI] [PubMed] [Google Scholar]

Articles from The Kaohsiung Journal of Medical Sciences are provided here courtesy of Kaohsiung Medical University and John Wiley & Sons Australia, Ltd

RESOURCES